ATE174785T1 - Behandlung von akne oder von folliculitis barbae - Google Patents

Behandlung von akne oder von folliculitis barbae

Info

Publication number: ATE174785T1
Authority: AT; Austria
Prior art keywords: acne; treatment; folliculitis barbae; barbae; folliculitis
Prior art date: 1991-10-30

Application number

AT92922984T

Other languages

English (en)

Inventor

Douglas Shander

F Eugene Harrington

Mary Claire Whitmore

Original Assignee

Gillette Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-30

Filing date

1992-10-28

Publication date

1999-01-15

1992-10-28 Application filed by Gillette Co filed Critical Gillette Co

1999-01-15 Application granted granted Critical

1999-01-15 Publication of ATE174785T1 publication Critical patent/ATE174785T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Birds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AT92922984T 1991-10-30 1992-10-28 Behandlung von akne oder von folliculitis barbae ATE174785T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/785,032 US5328686A (en)	1991-10-30	1991-10-30	Treatment of acne or of pseudofolliculitis barbae

Publications (1)

Publication Number	Publication Date
ATE174785T1 true ATE174785T1 (de)	1999-01-15

Family

ID=25134267

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92922984T ATE174785T1 (de)	1991-10-30	1992-10-28	Behandlung von akne oder von folliculitis barbae

Country Status (16)

Country	Link
US (1)	US5328686A (de)
EP (1)	EP0610368B1 (de)
JP (1)	JP3534751B2 (de)
KR (1)	KR100264829B1 (de)
AT (1)	ATE174785T1 (de)
AU (1)	AU675918B2 (de)
CA (1)	CA2121484C (de)
DE (1)	DE69228000T2 (de)
DK (1)	DK0610368T3 (de)
ES (1)	ES2125276T3 (de)
HU (1)	HU219949B1 (de)
OA (1)	OA09920A (de)
RU (1)	RU2130768C1 (de)
UA (1)	UA61870C2 (de)
WO (1)	WO1993008790A1 (de)
ZA (1)	ZA928345B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5851537A (en) *	1996-02-02	1998-12-22	Cancer Technologies, Inc.	Topical application of α-DFMO for preventing skin cancer
US6121269A (en) *	1999-02-22	2000-09-19	Henry; James P.	Reduction of hair growth
US6235737B1 (en)	2000-01-25	2001-05-22	Peter Styczynski	Reduction of hair growth
US6299865B1 (en)	2000-05-02	2001-10-09	Peter Styczynski	Reduction of hair growth
US7439271B2 (en)	2001-06-27	2008-10-21	The Gillette Company	Reduction of hair growth
US6743822B2 (en)	2001-08-10	2004-06-01	The Gillette Company	Reduction of hair growth
US7261878B2 (en) *	2001-08-10	2007-08-28	The Gillette Company	Reduction of hair growth
US20030036561A1 (en) *	2001-08-10	2003-02-20	Peter Styczynski	Reduction of hair growth
US20040198821A1 (en) *	2002-01-29	2004-10-07	Hwang Cheng Shine	Reduction of hair growth
US7160921B2 (en) *	2002-01-29	2007-01-09	The Gillette Company	Reduction of hair growth
US20030199584A1 (en) *	2002-04-11	2003-10-23	Ahluwalia Gurpreet S.	Reduction of hair growth
US20040141935A1 (en) *	2003-01-21	2004-07-22	Peter Styczynski	Reduction of hair growth
US7015349B2 (en) *	2003-03-26	2006-03-21	The Gillette Company	Reduction of hair growth
US20050031699A1 (en) *	2003-06-26	2005-02-10	L'oreal	Porous particles loaded with cosmetically or pharmaceutically active compounds
US20050249685A1 (en) *	2004-04-27	2005-11-10	Natalia Botchkareva	Reduction of hair growth
CA2567311A1 (en) *	2004-06-14	2005-12-22	Unilever Plc	Method of decreasing sebum production and pore size
US20070032781A1 (en) *	2004-12-22	2007-02-08	Henry James P	Reduction of hair growth
WO2006069192A1 (en) *	2004-12-22	2006-06-29	The Gillette Company	Reduction of hair growth with survivin inhibitors
US20060263438A1 (en) *	2005-05-17	2006-11-23	L'oreal	Gelled oil particles for targeting sebaceous glands and/or hair follicles
US7618956B2 (en) *	2005-05-31	2009-11-17	The Gillette Company	Reduction of hair growth
US20070059264A1 (en) *	2005-09-13	2007-03-15	Ahluwalia Gurpreet S	Reduction of hair growth
US7727516B2 (en) *	2006-02-28	2010-06-01	The Procter & Gamble Company	Reduction of hair growth
US20080206363A1 (en) *	2007-02-28	2008-08-28	Steve Harlan	Skin stabilizer preparation
FR2944443B1 (fr)	2009-04-21	2012-11-09	Arkema France	Procede de fabrication de particules de poudre libre a base de polyamide impregnee, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique
FR2953716B1 (fr)	2009-12-16	2015-03-27	Oreal	Kit de formulation d'un produit cosmetique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4161540A (en) *	1966-08-22	1979-07-17	Schering Corporation	Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US4139638A (en) *	1976-09-23	1979-02-13	Schering Corporation	Methods for the treatment of hirsutism
US4207315A (en) *	1976-10-20	1980-06-10	University Patents, Inc.	Process for treating proliferative skin diseases using certain diamino compounds
GB1573036A (en) *	1977-05-05	1980-08-13	Farmaceutici Italia	Anthracyclines
DE2840144A1 (de) *	1978-09-15	1980-03-27	Goedecke Ag	Topisch applizierbares arzneimittel mit antiandrogener wirkung
US4228163A (en) *	1979-03-30	1980-10-14	Dermik Laboratories	Method for treating pseudofolliculitis barbae
DE2943776A1 (de) *	1979-10-26	1981-05-14	Schering Ag Berlin Und Bergkamen, 1000 Berlin	17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
US4463016A (en) *	1982-09-22	1984-07-31	Nel's Laboratory, Inc.	Method for the treatment of razor bumps
US4525344A (en) *	1983-08-15	1985-06-25	Tutsky Ronald J	Skin care and shaving composition
US4720489A (en) *	1984-10-15	1988-01-19	Douglas Shander	Hair growth modification with ornithine decarboxylase inhibitors
US4786651A (en) *	1986-02-03	1988-11-22	Allergan, Inc.	Treatment of cutaneous hyperproliferative dermatoses with manoalide
US4775530A (en) *	1987-01-06	1988-10-04	Perricone Nicholas V	Method for treatment and prevention of pseudofolliculitis barbae
US4944939A (en) *	1987-12-14	1990-07-31	Moore Milton D	Shaving preparation for treatment and prevention of PFB (Ingrown Hairs)

1991
- 1991-10-30 US US07/785,032 patent/US5328686A/en not_active Expired - Lifetime
1992
- 1992-10-28 UA UA94005502A patent/UA61870C2/uk unknown
- 1992-10-28 KR KR1019940701432A patent/KR100264829B1/ko not_active IP Right Cessation
- 1992-10-28 ZA ZA928345A patent/ZA928345B/xx unknown
- 1992-10-28 AU AU29060/92A patent/AU675918B2/en not_active Expired
- 1992-10-28 WO PCT/US1992/009128 patent/WO1993008790A1/en active IP Right Grant
- 1992-10-28 JP JP50851193A patent/JP3534751B2/ja not_active Expired - Fee Related
- 1992-10-28 RU RU94022017A patent/RU2130768C1/ru active
- 1992-10-28 DE DE69228000T patent/DE69228000T2/de not_active Expired - Lifetime
- 1992-10-28 AT AT92922984T patent/ATE174785T1/de active
- 1992-10-28 HU HU9401258A patent/HU219949B1/hu unknown
- 1992-10-28 EP EP92922984A patent/EP0610368B1/de not_active Expired - Lifetime
- 1992-10-28 CA CA002121484A patent/CA2121484C/en not_active Expired - Lifetime
- 1992-10-28 ES ES92922984T patent/ES2125276T3/es not_active Expired - Lifetime
- 1992-10-28 DK DK92922984T patent/DK0610368T3/da active
1994
- 1994-04-29 OA OA60503A patent/OA09920A/en unknown

Also Published As

Publication number	Publication date
UA61870C2 (en)	2003-12-15
HUT70393A (en)	1995-10-30
DE69228000D1 (de)	1999-02-04
EP0610368B1 (de)	1998-12-23
US5328686A (en)	1994-07-12
DE69228000T2 (de)	1999-08-12
OA09920A (en)	1994-09-15
JPH07500606A (ja)	1995-01-19
AU2906092A (en)	1993-06-07
CA2121484A1 (en)	1993-05-13
RU2130768C1 (ru)	1999-05-27
CA2121484C (en)	1999-01-19
WO1993008790A1 (en)	1993-05-13
RU94022017A (ru)	1996-08-27
MX9206239A (es)	1998-11-30
EP0610368A1 (de)	1994-08-17
EP0610368A4 (de)	1994-12-21
JP3534751B2 (ja)	2004-06-07
HU9401258D0 (en)	1994-08-29
HU219949B1 (en)	2002-09-28
DK0610368T3 (da)	1999-08-23
KR100264829B1 (ko)	2000-11-01
ES2125276T3 (es)	1999-03-01
AU675918B2 (en)	1997-02-27
ZA928345B (en)	1993-05-11

Publication	Publication Date	Title
ATE174785T1 (de)	1999-01-15	Behandlung von akne oder von folliculitis barbae
MY119711A (en)	2005-07-29	Method of inhibiting photoaging of skin
ATE209483T1 (de)	2001-12-15	Behandlung von multipler sklerose
DE69429427D1 (de)	2002-01-24	Behandlung von tumoren mit verbindungen mit einer rxr-retinoid agonistische wirkung
ATE289508T1 (de)	2005-03-15	Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom
ATE266417T1 (de)	2004-05-15	Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
PT971713E (pt)	2003-09-30	Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ATE258796T1 (de)	2004-02-15	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE321548T1 (de)	2006-04-15	Verwendung von statin zur behandlung von hauterkrankungen
DK0723444T3 (da)	1997-12-29	Levobupivacain, som er egnet til behandling af kronisk smerte
DE68907423D1 (de)	1993-08-12	Behandlung der akne.
DE69116380D1 (de)	1996-02-22	Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE222101T1 (de)	2002-08-15	Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
ATE293972T1 (de)	2005-05-15	Behandlung von chronischen schmerzen
ATE206052T1 (de)	2001-10-15	Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DZ1765A1 (fr)	2002-02-17	Sel de (s)-phéneyl-2-pyridineéthanamine utile pourune thérapie.
DE3674321D1 (de)	1990-10-25	Behandlung geschmeidiger gewebe.
ATE369143T1 (de)	2007-08-15	Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69635282D1 (de)	2006-02-23	Behandlung der exzessiven aggressivität mit olanzapine
ATE302605T1 (de)	2005-09-15	Tazaroten und uvb-phototherapie zur behandlung von psoriasis
JPS51121530A (en)	1976-10-23	Toiletries
ATE209941T1 (de)	2001-12-15	Arzneigeräte für die behandlung von blutgefässen mittels ionisierungsbestrahlung
UA8280A (uk)	1996-03-29	Спосіб лікування псоріазу
ATE336282T1 (de)	2006-09-15	Katheter zur behandlung von prostaterkrankungen
ATE91231T1 (de)	1993-07-15	Behandlung der akne.

Legal Events

Date	Code	Title	Description
1999-12-15	UEP	Publication of translation of european patent specification